Drug Name |
Company Information |
Related
Information |
Agenerase (amprenavir) 150mg capsule
updated 10/10/2007 |
GlaxoSmithKline
888-825-5249
|
Letter from GlaxoSmithKline
(updated 10/10/2007) |
5% Alcohol in 5% Dextrose Injection, USP, Glass Container
12/19/2007 |
Hospira, Inc.
877-946-7747 |
Hospira has made a business decision to discontinue manufacturing of 5% Alcohol in 5% Dextrose Injection drug product (NDC# 0409-1500-05) |
Brevibloc Concentrate (esmolol HCl) 250 mg/mL, 10 mL ampul
8/24/2007 |
Baxter Healthcare Corporation |
Baxter Healthcare Corporation has made a decision to discontinue Brevibloc Concentrate (esmolol HCl) 250 mg/mL, 10 mL ampul (NDC 10019-025-18 for the pack and NDC 10019-025-73 for the ampul). Letter from Baxter  |
Calciferol injection in oil (ergocalciferol)
3/19/2004 |
Schwarz Pharma
6140 W. Executive Drive
Mequon, WI 53092
800-558-5114
|
Schwarz has discontinued manufacturing
of calciferol
|
CEFOTAN (cefotetan injection) 6/9/2006 |
AstraZeneca Pharmaceuticals LP (AstraZeneca) - Contact Corporate
Information Center at 800-236-9933. |
The remaining inventory of CEFOTAN (cefotetan
injection) has been depleted. AstraZeneca has no further plans to
manufacture or distribute CEFOTAN (cefotetan injection). Other cefotetan injection products continue to be available.
|
Cortisporin Ophthalmic Suspension (neomycin and polymyxin B sulfates and hydrocortisone ophthalmic suspension)
6/5/2008 |
King Pharmaceuticals
800-776-3637 |
Letter from King Pharmaceuticals |
Cortisporin Otic Suspension (neomycin and polymyxin B sulfates and hydrocortisone otic suspension, USP)
6/5/2008 |
King Pharmaceuticals
800-776-3637 |
Letter from King Pharmaceuticals |
Cylert (pemoline) tablets and chewable
tablets, all strengths
5/25/2005
|
Abbott Laboratories
|
Abbott has made the decision to
discontinue Cylert tablets and chewable tablets
Letter from
Abbott
 |
Cytoxan (cyclophosphamide) 25mg and 50mg tablets
9/24/2007 |
Bristol-Myers Squibb Company
609-897-2412 |
Bristol-Myers Squibb Company has made a decision to discontinue Cytoxan (cyclophosphamide) 25mg and 50mg tablets. Alternate products continue to be available from other companies. |
Desyrel (trazodone) Tablets 50mg, 100mg,
150mg and 300mg tablets 9/21/2006
|
Bristol-Myers Squibb Company
609-897-2412 |
Alternate products continue to be available from other companies.
Dear Healthcare Professional Letter
 |
ELAVIL (amitriptyline hydrochloride) Tablets and Injection.
5/15/2003 |
AstraZeneca Pharmaceuticals LP (AstraZeneca) – Contact Corporate
Information Center at
800-236-9933 |
ELAVIL Injection is no longer available at AstraZeneca. The
remaining inventory of ELAVIL Tablets will be depleted by December
31, 2003. AstraZeneca has no further plans to manufacture ELAVIL (amitriptyline
hydrochloride) Tablets or Injection. |
Enlon (edrophonium chloride) injection and Enlon Plus (edrophonium chloride and atropine sulfate) injection
2/29/2008 |
Baxter Healthcare Corporation |
Letter from Baxter Healthcare Corporation  |
Ethmozine (moricizine hydrochloride) 200mg, 250g, and 300mg tablets
9/17/2007 |
Shire US Inc.
725 Chesterbrook Blvd.
Wayne, Pa 19087
1-800-828-2088 |
Dear Healthcare Professional Letter  |
Exubera (insulin recombinant human, powder for inhalation)
10/19/2007 |
Pfizer
800-398-2372 |
Dear Healthcare Provider Letter  |
Florinef (fludrocortisone acetate tablets, USP)
6/8/2007 |
King Pharmaceuticals, Inc. 501 Fifth Street Bristol, Tennessee 37620 Professional Information Services Department:
800-776-3637 |
Dear Healthcare Provider Letter  |
Flovent Rotadisk (fluticasone
propionate inhalation powder)
8/31/2004 |
GlaxoSmithKline
888-825-5249 |
Please see
Dear Healthcare Professional letter
for
additional information.
|
Fortovase (saquinavir) capsules 200 mg
6/2/2005 |
Roche |
Fortovase 200 mg capsules will be
discontinued by February 15, 2006. Please see attached DHP letter
for additional information.
Dear Healthcare Professional Letter
|
Foscavir (foscarnet sodium) injection
10/31/2008 |
AstraZeneca Pharmaceuticals LP (AstraZeneca)
Contact Corporate Information Center at 1-800-236-9933
|
The remaining inventory of Foscavir (foscarnet sodium) injection will be depleted by April 30, 2009. AstraZeneca has no further plans to manufacture or distribute Foscavir (foscarnet sodium) injection after April 30, 2009.
|
Geocillin (carbenicillin indanyl sodium) tablets 382 mg
4/8/2008 |
Pfizer |
Pfizer has discontinued this product. There are no other FDA approved manufacturers currently for carbenicillin tablets. |
Geref Diagnostic (sermorelin acetate for injection) 0.05mg base/amp
8/5/2008 |
EMD Serono 1-888-398-4567 |
EMD Serono has made a business decision to discontinue this product.
Dear Healthcare Professional Letter 
|
Humatin (Paromomycin Sulfate Capsules, USP)
2/7/2008 |
King Pharmaceuticals Professional Information Services Department
800-776-3637 |
King Pharmaceuticals has made a decision to discontinue Humatin (Paromomycin Sulfate Capsules, USP) Paromomycin continues to be available from another manufacture.
Letter from King Pharmaceuticals  |
Humulin U ULTRALENTE (HUMAN INSULIN [rDNA
ORIGIN] EXTENDED ZINC SUSPENSION)
7/6/2005 |
Eli Lilly and Company |
Dear Doctor
Letter

Patient
Information
 |
Humulin L LENTE (HUMAN INSULIN [rDNA
ORIGIN] ZINC SUSPENSION)
7/6/2005 |
Eli Lilly and Company |
Dear Doctor
Letter

Patient
Information

|
HIVID (zalcitabine) tablets 7/26/2006
|
Roche Pharmaceuticals |
The sale and distribution of its anti-HIV
medication HIVID (zalcitabine) Tablets will be discontinued by
December 31, 2006.Dear
Health Care Professional Letter
 |
Intal Nebulizer Solution (cromolyn sodium inhalation solution, USP)
6/2/2008 |
King Pharmaceuticals
800-776-3637 |
Letter from King Pharmaceuticals.  |
Inulin in Sodium Chloride Injection, USP
9/26/2003
|
Questcor Pharmaceuticals, Inc. |
Letter
 |
Kefzol (cefazolin) all presentations
2/28/2003 |
Eli Lilly and Company |
Letter |
Kefurox (cefuroxime)
all presentations 2/28/2003 |
Eli Lilly and Company |
Letter |
Kemadrin (procyclidine hydrochloride)
6/6/2008 |
King Pharmaceuticals
800-776-3637 |
Letter from King Pharmaceuticals |
Lanoxin Elixir(digoxin)
6/3/2005 |
GlaxoSmithKline |
This product has been discontinued by
GSK.
Roxane is producing digoxin elixir.
|
LEXXEL (enalapril maleate-felodipine ER) Tablets
12/19/2007 |
AstraZeneca LP (AstraZeneca) - Contact Corporate Information Center at
800-236-9933. |
LEXXEL Tablets will be discontinued on July 31, 2008. AstraZeneca has no further plans to manufacture or distribute LEXXEL (enalapril maleate-felodipine ER) Tablets after July 31, 2008. |
Lorabid (loracarbef, USP) capsules and suspension
10/27/2006 |
King Pharmaceuticals 888-840-5370 |
Letter from King Pharmaceuticals  |
Mandol (cefamandole)
all presentations 2/28/2003 |
Eli Lilly and Company |
Letter |
Mitozytrex (Mitomycin
for Injection)
9/12/2008 |
SuperGen
(925) 560-0100
|
Other Mitomycin approved products continue to be available.
This product was never commercialized.
|
Mivacron (mivacurium chloride) injection
6/23/2006 |
Abbott Laboratories |
Alternative products that can be used in place of Mivacron
continue to be available. Please call Abbott at 1-800-633-9110 for
additional information.
|
Neutrexin (trimetrexate glucuronate) Injection
6/14/2007 |
MedImmune, Inc. |
Dear Healthcare Professional Letter  |
Nimotop (nimodipine) capsules
10/31/2008 |
Bayer HealthCare Pharmaceuticals 888-842-2937 |
Generic nimodipine remains available.
Please see Dear Healthcare Professional Letter for additional information.
|
Nolvadex (tamoxifen citrate) 4/10/2006
|
AstraZeneca
800-236-9933 |
Letter
 |
Novolin L, Lente, human insulin zinc suspension [rDNA origin]
7/15/2003
|
Novo Nordisk Pharmaceuticals, Inc.
Contact:
800-727-6500 Customer Service
|
Letter |
NPH Iletin II (ISOPHANE INSULIN
SUSPENSION, USP, PURIFIED PORK)
7/6/2005 |
Eli Lilly and Company |
|
ORLAAM (Levomethadyl hydrochloride acetate) Oral Solution, 10 mg/mL
9/2/2003 |
Roxane Laboratories |
Letter |
Pancrease (pancrelipase) capsules
5/17/2006 |
McNeil Consumer and Specialty Pharmaceuticals
888-440-7903 |
Other pancrelipase products continue to be available
Dear Health Care Provider Letter

|
Perchloracap
(potassium perchlorate) 200 mg capsules
6/2/2005 |
Tyco Healthcare |
Perchloracap capsules have been discontinued and supplies are
anticipated to be depleted by the end of 2005. |
Pre-Pen (benzylpenicilloyl polylysine)
injection
4/13/2005 |
Hollister-Stier
800-992-1120
|
Pre-Pen is no longer available. |
Procanbid (Procanamide Hydrochloride Extended-Release Tablets)
11/9/2007 |
King Pharmaceuticals 800-776-3637 |
Dear Prescriber Letter  |
ProSom (estazolam) Updated
5/2/2007 |
Abbott
200 Abbott Park Road Abbott Park, IL 60064-6157
Customer Service: 800-633-9110 |
Dear Health Care Provider Letter  |
Pulmicort Turbuhaler 200mcg (budesonide inhalation powder)
5/16/2007 |
AztraZeneca
1800 Concord Pike PO Box 8355 Wilmington DE 19803-8355
Corporate Information:
800-842-9920 |
NDA 20-441, PULMICORT TURBUHALER 200 mcg (budesonide inhalation powder) will no longer be available at AstraZeneca.
The introduction of PULMICORT FLEXHALER (budesonide inhalation powder, 90 & 180 mcg), NDA 21-949, will be accompanied by the phasing out of PULMICORT TURBUHALER so as to minimize confusion in the marketplace.
AstraZeneca has no further plans to manufacture NDA 20-441, PULMICORT TURBUHALER 200 mcg (budesonide inhalation powder). |
Regular Iletin II (INSULIN INJECTION,
USP, PURIFIED PORK)
7/6/2005 |
Eli Lilly and Company |
|
Revex (Nalmefene HCl Injection) 1mg/mL, 2 mL ampule and 0.1mg/mL, 1mL ampule
7/9/2008 |
Baxter Healthcare Corporation
888-229-0001
|
Baxter has discontinued Revex production. |
Roferon-A (Interferon alfa-2a, Recombinant)
11/29/2007 |
Hoffmann -La Roche Inc.
800-526-6367 |
Dear Healthcare Professional Letter  |
SecreFlo (porcine secretin for injection, 16 mcg/vial)
10/1/2008 |
ChiRhoClin, Inc., 1-877-272-4888
|
Please see Dear Healthcare Professional Letter for additional information. |
Serevent Inhalation Aerosol
6/10/2003 |
GlaxoSmithKline
800-340-3236 |
GSK anticipates that SEREVENT Inhalation Aerosol will no longer be
available starting in June 2003.
Dear Health Care Professional
Letter from GlaxoSmithKline
|
Sporanox (itraconazole) Injection
10/11/2007 |
Ortho Biotech |
Please see Dear Health Care Professional letter for additional information. |
Stelazine (trifluoperazine) oral
concentrate 10mg/ml Stelazine
(trifluoperazine) tablets (1mg, 2mg, 5mg, 10mg)
Stelazine (trifluoperazine)
Injection 2mg/ml
12/18/2003 |
GlaxoSmithKline
888-825-5249
|
Stelazine was discontinued and
withdrawn from the market. The final lots were distributed by GSK
August 2003 and the final expiry date of all products in the
marketplace is no later than January 31, 2004.
|
Suprax (cefixime)
updated 2/25/2004 |
Lederle/Wyeth Pharmaceuticals |
Discontinued July 2002. Stock will be distributed until exhausted
or until March 2003, whichever comes first. For additional
information, please call customer service (800) 666-7248
Lupin Pharmaceuticals recently
received approval for cefixime 400 mg tablets and cefixime 100
mg/5 ml suspension. For further information, please contact Lupin
Pharmaceuticals at 410-576-2000 (2/25/2004) |
Tenormin (atenolol) 0.5mg/ml Injection
2/28/2008 |
AstraZeneca Pharmaceuticals LP (AstraZeneca) – Contact Corporate Information Center:
800-236-9933 |
AstraZeneca has made a business decision to discontinue Tenormin (atenolol) 0.5 mg/ml injection. |
Teslac (testolactone tablets, USP) 50mg tablets
2/26/2008 |
Bristol-Myers Squibb
609-897-2412 |
Bristol-Myers Squibb Company has made a decision to discontinue Teslac (testolactone tablets, USP) 50mg tablets.
Letter from Bristol-Myers Squibb  |
Tequin (gatifloxacin) Tablets and Injection
5/12/2006 |
Bristol-Meyers Squibb
|
See attached letter.
 |
Tilade Inhaler (nedocromil sodium inhalation aerosol)
5/2/2008 |
King Pharmaceuticals
800-776-3637 |
Dear Healthcare Professional Letter (4/30/2008) |
Valstar (valrubicin) Solution for
Intravesical Instillation
1/30/2004 |
Formerly distributed by Celltech
Celltech
Customer Service
888-963-3382
|
No
further availability planned at this time. |
Velosulin BR Human, Buffered Regular
Human Insulin Injection [rDNA origin]
11/3/2003
|
Novo Nordisk Pharmaceuticals, Inc.
Contact:
800-727-6500
Customer Service
|
Dear
Healthcare Professional Letter
 |
Videx (didanosine) chewable/dispersable
buffered tablets 9/19/2006 |
BMS |
Dear Healthcare Professional Letter

|
1.5% Xylocaine -MPF with Dextrose 7.5% Injection (lidocaine HCl
and dextrose anhydrous Injection ampules)
8/29/2005
|
AstraZeneca
800-842-9920
|
1.5% Xylocaine® -MPF with Dextrose 7.5% Injection is no longer
available at AstraZeneca. The remaining inventory of 1.5%
Xylocaine® -MPF with Dextrose 7.5% Injection Ampules will be
depleted by August 31, 2005. AstraZeneca has no further plans to
manufacture 1.5% Xylocaine® -MPF with Dextrose 7.5% Injection
Ampules
|
Zovirax (acyclovir sodium) for
injection 1000mg/20ml vial
1/6/2004 |
GlaxoSmithKline
Customer Service
800-877-1158
|
Letter from GSK
 |
Zyflo (zileuton) tablets
2/20/2008 |
Critical Therapeutics, Inc. |
Zyflo CR continues to be available.
Dear Healthcare Professional Letter  |